{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T14:18:56Z","timestamp":1791555536876,"version":"4.3.4"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T00:00:00Z","timestamp":1729468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Atropine is an effective medicine for myopia prevention and control. This meta-analysis was conducted to investigate the effects of atropine on choroidal thickness (ChT) in children with myopia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Between its inception and 1 June 2023, Medline, Embase, and Web of Science were all searched, and only English literature was included. The choroidal thickness was the primary study outcome. Axial length, standardized equivalent refraction were examined as secondary outcomes. STATA 12.0 was used for data extraction and analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 307 eyes were involved in this study to evaluate the effect of atropine on ChT, axial length (AL) and standardized equivalent refraction (SER) in myopic children. Choroidal thickening was significantly higher in the atropine group than in the control group at 1\u00a0month (WMD, 6.87\u00a0mm, 95% CI, 0.04 to 13.10,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.049), whereas it was significantly higher in the atropine group than in the control group at months 6 (WMD, 10.37\u00a0mm, 95% CI, \u22123.21 to 23.95,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.135), 12 (WMD, 15.10\u00a0mm, 95% CI, \u22125.08 to 35.27,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.143) and at final follow-up (WMD, 11.52\u00a0mm, 95% CI, \u22123.26 to 26.31,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.127), the differences were not statistically significant. At months 1 (WMD, \u22120.03\u00a0mm, 95% CI, \u22120.04 to \u22120.01,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.003), 6 (WMD, \u22120.07\u00a0mm, 95% CI, \u22120.01 to \u22120.03,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.000), 12 (WMD, \u22120.13mm, 95% CI, \u22120.15 to \u22120.11,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.843), and at final follow-up (WMD, \u22120.08\u00a0mm, 95% CI, \u22120.16 to \u22120.01,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.127), atropine treatment was able to delay the axial elongation. At 1-month follow-up, there was no significant difference in the effect of atropine on SER in myopic children compared with the control group (WMD, 0.01D, 95% CI, \u22120.07 to 26.31,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.127), whereas it was able to control the progression of refractive status at final follow-up (WMD, 11.52\u00a0mm, 95% CI, \u22123.26 to 26.31,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.127).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Limited evidence suggests that 0.01% atropine causes choroidal thickening in myopic children at 1\u00a0month of treatment. In the short term, choroidal thickness may be a predictor of the effectiveness of atropine in controlling myopia in children. 0.01% atropine is effective in controlling myopic progression in terms of SER and AL.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic Review Registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>http:\/\/www.crd.york.ac.uk\/prospero<\/jats:ext-link>\n                      , identifier, CRD42022381195.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2024.1440180","type":"journal-article","created":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T09:07:39Z","timestamp":1729501659000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Effects of atropine on choroidal thickness in myopic children: a meta-analysis"],"prefix":"10.3389","volume":"15","author":[{"given":"Yaqi","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,10,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41598-016-0002-7","article-title":"Nitric oxide (NO) mediates the inhibition of form-deprivation myopia by atropine in chicks","volume":"6","author":"Carr","year":"2016","journal-title":"Sci. Rep."},{"key":"B2","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3109\/02713683.2014.973043","article-title":"Correlation of macular choroidal thickness with concentrations of aqueous vascular endothelial growth factor in high myopia","volume":"40","author":"Chen","year":"2015","journal-title":"Curr. eye Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ophtha.2011.07.031","article-title":"Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (Atropine for the Treatment of Myopia 2)","volume":"119","author":"Chia","year":"2012","journal-title":"Ophthalmology"},{"key":"B4","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.ajo.2013.09.020","article-title":"Atropine for the treatment of childhood myopia: changes after stopping atropine 0.01%, 0.1% and 0.5%","volume":"157","author":"Chia","year":"2014","journal-title":"Am. J. Ophthalmol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.ophtha.2015.07.004","article-title":"Five-year clinical trial on atropine for the treatment of myopia 2: myopia control with atropine 0.01% eyedrops","volume":"123","author":"Chia","year":"2016","journal-title":"Ophthalmology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"8528315","DOI":"10.1155\/2018\/8528315","article-title":"Effect of atropine eye drops on choroidal thinning induced by hyperopic retinal defocus","volume":"2018","author":"Chiang","year":"2018","journal-title":"J. Ophthalmol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.exer.2006.09.019","article-title":"Effects of intravitreally and intraperitoneally injected atropine on two types of experimental myopia in chicken","volume":"84","author":"Diether","year":"2007","journal-title":"Exp. eye Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/519276a","article-title":"The myopia boom","volume":"519","author":"Dolgin","year":"2015","journal-title":"Nature"},{"key":"B9","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1006\/exer.2002.1142","article-title":"Temporal relationship of choroidal blood flow and thickness changes during recovery from form deprivation myopia in chicks","volume":"74","author":"Fitzgerald","year":"2002","journal-title":"Exp. eye Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.preteyeres.2012.06.004","article-title":"The complex interactions of retinal, optical and environmental factors in myopia aetiology","volume":"31","author":"Flitcroft","year":"2012","journal-title":"Prog. Retin. eye Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"730","DOI":"10.5301\/ejo.5000965","article-title":"Choroidal thickness and ametropia in children: a longitudinal study","volume":"27","author":"Fontaine","year":"2017","journal-title":"Eur. J. Ophthalmol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"728","DOI":"10.2471\/BLT.12.104034","article-title":"Global cost of correcting vision impairment from uncorrected refractive error","volume":"90","author":"Fricke","year":"2012","journal-title":"Bull. World Health Organ."},{"key":"B13","doi-asserted-by":"publisher","first-page":"e585","DOI":"10.1111\/aos.12631","article-title":"Choroidal thickness and high myopia: a case-control study of young Chinese men in Singapore","volume":"93","author":"Gupta","year":"2015","journal-title":"Acta Ophthalmol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.1007\/s10792-021-01855-5","article-title":"Changes in subfoveal choroidal thickness in myopic children with 0.01% atropine, orthokeratology, or their combination","volume":"41","author":"Hao","year":"2021","journal-title":"Int. Ophthalmol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.ophtha.2016.01.006","article-title":"Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050","volume":"123","author":"Holden","year":"2016","journal-title":"Ophthalmology"},{"key":"B16","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.visres.2008.10.008","article-title":"Spectacle lens compensation in the pigmented Guinea pig","volume":"49","author":"Howlett","year":"2009","journal-title":"Vis. Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.ophtha.2015.11.010","article-title":"Efficacy comparison of 16 interventions for myopia control in children: a network meta-analysis","volume":"123","author":"Huang","year":"2016","journal-title":"Ophthalmology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1097\/IAE.0000000000002090","article-title":"Longitudinal changes in choroidal and retinal thicknesses in children with myopic shift","volume":"39","author":"Jin","year":"2019","journal-title":"Retina Phila. Pa."},{"key":"B19","volume-title":"Webvision: The Organization of the Retina and Visual System [Internet]","author":"Kolb","year":"1995"},{"key":"B20","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1111\/aos.14773","article-title":"The influence of the choroid on the onset and development of myopia: from perspectives of choroidal thickness and blood flow","volume":"99","author":"Liu","year":"2021","journal-title":"Acta Ophthalmol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.exer.2009.02.019","article-title":"Axial myopia induced by hyperopic defocus in Guinea pigs: a detailed assessment on susceptibility and recovery","volume":"89","author":"Lu","year":"2009","journal-title":"Exp. eye Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"567","DOI":"10.13703\/j.0255-2930.2015.06.01","article-title":"Clinical observation on therapeutic effect of myopia in children treated with abdominal acupuncture","volume":"35","author":"Lv","year":"2015","journal-title":"Zhongguo zhen jiu = Chin. Acupunct. and moxibustion"},{"key":"B23","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00417-022-05837-w","article-title":"Studies on the interactions of retinal dopamine with choroidal thickness in the chicken","volume":"261","author":"Mathis","year":"2023","journal-title":"Graefe's archive Clin. Exp. Ophthalmol. Albrecht von Graefes Archiv fur klinische und Exp. Ophthalmol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s00417-019-04573-y","article-title":"Studies on retinal mechanisms possibly related to myopia inhibition by atropine in the chicken","volume":"258","author":"Mathis","year":"2020","journal-title":"Graefe's archive Clin. Exp. Ophthalmol. Albrecht von Graefes Archiv fur klinische und Exp. Ophthalmol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"453","DOI":"10.18240\/ijo.2023.03.17","article-title":"Choroidal thickness, myopia, and myopia control interventions in children: a Meta-analysis and systemic review","volume":"16","author":"Meng","year":"2023","journal-title":"Int. J. Ophthalmol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.preteyeres.2017.09.004","article-title":"The epidemics of myopia: aetiology and prevention","volume":"62","author":"Morgan","year":"2018","journal-title":"Prog. Retin. eye Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1016\/s0140-6736(12)60272-4","article-title":"Myopia","volume":"379","author":"Morgan","year":"2012","journal-title":"Lancet London, Engl."},{"key":"B28","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.exer.2007.01.017","article-title":"Transient increases in choroidal thickness are consistently associated with brief daily visual stimuli that inhibit ocular growth in chicks","volume":"84","author":"Nickla","year":"2007","journal-title":"Exp. eye Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.preteyeres.2009.12.002","article-title":"The multifunctional choroid","volume":"29","author":"Nickla","year":"2010","journal-title":"Prog. Retin. eye Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/opo.12054","article-title":"Effects of muscarinic agents on chick choroids in intact eyes and eyecups: evidence for a muscarinic mechanism in choroidal thinning","volume":"33","author":"Nickla","year":"2013","journal-title":"Ophthalmic and physiological Opt. J. Br. Coll. Ophthalmic Opt. (Optometrists)"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1016\/j.ophtha.2017.05.032","article-title":"Atropine for the prevention of myopia progression in children: a report by the American academy of ophthalmology","volume":"124","author":"Pineles","year":"2017","journal-title":"Ophthalmology"},{"key":"B32","doi-asserted-by":"publisher","first-page":"63","DOI":"10.2471\/blt.07.041210","article-title":"Global magnitude of visual impairment caused by uncorrected refractive errors in 2004","volume":"86","author":"Resnikoff","year":"2008","journal-title":"Bull. World Health Organ."},{"key":"B33","doi-asserted-by":"publisher","first-page":"4782536","DOI":"10.1155\/2019\/4782536","article-title":"Short-term effect of low-dose atropine and hyperopic defocus on choroidal thickness and axial length in young myopic adults","volume":"2019","author":"Sander","year":"2019","journal-title":"J. Ophthalmol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.ophtha.2011.10.029","article-title":"Choroidal thickness and volume mapping by a six radial scan protocol on spectral-domain optical coherence tomography","volume":"119","author":"Shin","year":"2012","journal-title":"Ophthalmology"},{"key":"B35","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/eye.2013.277","article-title":"Visual regulation of refractive development: insights from animal studies","volume":"28","author":"Smith","year":"2014","journal-title":"Eye Lond. Engl."},{"key":"B36","doi-asserted-by":"publisher","first-page":"101723","DOI":"10.1016\/j.clae.2022.101723","article-title":"Combined 0.01% atropine with orthokeratology in childhood myopia control (AOK) study: a 2-year randomized clinical trial","volume":"46","author":"Tan","year":"2023","journal-title":"Contact lens and anterior eye J. Br. Contact Lens Assoc."},{"key":"B37","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/09273972.2016.1276940","article-title":"Interventions to reduce myopia progression in children","volume":"25","author":"Tay","year":"2017","journal-title":"Strabismus"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1001\/jamaophthalmol.2016.4009","article-title":"Association of axial length with risk of uncorrectable visual impairment for Europeans with myopia","volume":"134","author":"Tideman","year":"2016","journal-title":"JAMA Ophthalmol."},{"key":"B39","first-page":"1249","article-title":"Choroidal thickness changes during altered eye growth and refractive state in a primate","volume":"41","author":"Troilo","year":"2000","journal-title":"Investigative Ophthalmol. and Vis. Sci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0042-6989(94)e0049-q","article-title":"Moving the retina: choroidal modulation of refractive state","volume":"35","author":"Wallman","year":"1995","journal-title":"Vis. Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.neuron.2004.08.008","article-title":"Homeostasis of eye growth and the question of myopia","volume":"43","author":"Wallman","year":"2004","journal-title":"Neuron"},{"key":"B42","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s40123-022-00476-0","article-title":"Short-term effects of atropine 0.01% on the structure and vasculature of the choroid and retina in myopic Chinese children","volume":"11","author":"Wang","year":"2022","journal-title":"Ophthalmol. Ther."},{"key":"B43","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.ophtha.2012.07.048","article-title":"Subfoveal choroidal thickness: the Beijing eye study","volume":"120","author":"Wei","year":"2013","journal-title":"Ophthalmology"},{"key":"B44","doi-asserted-by":"publisher","first-page":"M106","DOI":"10.1167\/iovs.18-25958","article-title":"IMI - interventions myopia institute: interventions for controlling myopia onset and progression report","volume":"60","author":"Wildsoet","year":"2019","journal-title":"Investigative Ophthalmol. and Vis. Sci."},{"key":"B45","doi-asserted-by":"publisher","first-page":"103528","DOI":"10.1016\/j.pdpdt.2023.103528","article-title":"Changes in choroidal thickness in myopic children with 0.01% atropine: evidence from a 12-month follow-up","volume":"42","author":"Wu","year":"2023","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"B46","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1167\/iovs.64.4.13","article-title":"Potential choroidal mechanisms underlying atropine's antimyopic and rebound effects: a mediation analysis in a randomized clinical trial","volume":"64","author":"Xu","year":"2023","journal-title":"Investigative Ophthalmol. and Vis. Sci."},{"key":"B47","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.ophtha.2021.10.002","article-title":"Three-year clinical trial of low-concentration atropine for myopia progression (LAMP) study: continued versus washout: phase 3 report","volume":"129","author":"Yam","year":"2022","journal-title":"Ophthalmology"},{"key":"B48","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/cxo.13128","article-title":"Comparisons of atropine versus cyclopentolate cycloplegia in myopic children","volume":"104","author":"Ye","year":"2021","journal-title":"Clin. and Exp. optometry"},{"key":"B49","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1167\/iovs.61.14.15","article-title":"Effects of atropine treatment on choroidal thickness in myopic children","volume":"61","author":"Ye","year":"2020","journal-title":"Investigative Ophthalmol. and Vis. Sci."},{"key":"B50","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/bs.pmbts.2015.06.014","article-title":"RPE and choroid mechanisms underlying ocular growth and myopia","volume":"134","author":"Zhang","year":"2015","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"B51","doi-asserted-by":"publisher","first-page":"34936","DOI":"10.1038\/srep34936","article-title":"The effect of topical atropine on the choroidal thickness of healthy children","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci. Rep."},{"key":"B52","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1186\/s12886-020-01746-w","article-title":"Efficacy and safety of atropine to control myopia progression: a systematic review and meta-analysis","volume":"20","author":"Zhao","year":"2020","journal-title":"BMC Ophthalmol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"101348","DOI":"10.1016\/j.clae.2020.06.006","article-title":"Short-term effects of atropine combined with orthokeratology (ACO) on choroidal thickness","volume":"44","author":"Zhao","year":"2021","journal-title":"Contact lens and anterior eye J. Br. Contact Lens Assoc."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40662-020-00224-0","article-title":"Choroidal blood perfusion as a potential \"rapid predictive index\" for myopia development and progression","volume":"8","author":"Zhou","year":"2021","journal-title":"Eye Vis. Lond. Engl."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1440180\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T09:07:45Z","timestamp":1729501665000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1440180\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,21]]},"references-count":54,"alternative-id":["10.3389\/fphar.2024.1440180"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2024.1440180","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,21]]},"article-number":"1440180"}}